These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 21673279)

  • 1. Long-term open-label study of adjunctive topiramate in infants with refractory partial-onset seizures.
    Puri V; Ness S; Sattaluri SJ; Wang S; Todd M; Yuen E; Eerdekens M; Nye JS; Manitpisitkul P; Shalayda K; Ford L
    J Child Neurol; 2011 Oct; 26(10):1271-83. PubMed ID: 21673279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and safety of adjunctive topiramate in infants (1-24 months) with refractory partial-onset seizures: a randomized, multicenter, open-label phase 1 study.
    Manitpisitkul P; Shalayda K; Todd M; Wang SS; Ness S; Ford L
    Epilepsia; 2013 Jan; 54(1):156-64. PubMed ID: 23157581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adaptive behavior outcomes in infants treated with adjunctive topiramate.
    Ness S; Todd MJ; Wang S; Eerdekens M; Nye JS; Ford L
    Pediatr Neurol; 2012 Jun; 46(6):350-8. PubMed ID: 22633629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term migraine prevention with topiramate: open-label extension of pivotal trials.
    Rapoport A; Mauskop A; Diener HC; Schwalen S; Pfeil J
    Headache; 2006; 46(7):1151-60. PubMed ID: 16866719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
    Silberstein SD; Lipton RB; Dodick DW; Freitag FG; Ramadan N; Mathew N; Brandes JL; Bigal M; Saper J; Ascher S; Jordan DM; Greenberg SJ; Hulihan J;
    Headache; 2007 Feb; 47(2):170-80. PubMed ID: 17300356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjunctive levetiracetam in children, adolescents, and adults with primary generalized seizures: open-label, noncomparative, multicenter, long-term follow-up study.
    Delanty N; Jones J; Tonner F
    Epilepsia; 2012 Jan; 53(1):111-9. PubMed ID: 22050371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A long-term open-label extension study assessing cognition and behavior, tolerability, safety, and efficacy of adjunctive levetiracetam in children aged 4 to 16 years with partial-onset seizures.
    Schiemann-Delgado J; Yang H; Loge Cde L; Stalvey TJ; Jones J; Legoff D; Mintz M
    J Child Neurol; 2012 Jan; 27(1):80-9. PubMed ID: 21876066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized trial of adjunctive topiramate therapy in infants with refractory partial seizures.
    Novotny E; Renfroe B; Yardi N; Nordli D; Ness S; Wang S; Weber T; Kurland CL; Yuen E; Eerdekens M; Venkatraman L; Nye JS; Ford L
    Neurology; 2010 Mar; 74(9):714-20. PubMed ID: 20089937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perampanel, a selective, noncompetitive α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist, as adjunctive therapy for refractory partial-onset seizures: interim results from phase III, extension study 307.
    Krauss GL; Perucca E; Ben-Menachem E; Kwan P; Shih JJ; Squillacote D; Yang H; Gee M; Zhu J; Laurenza A
    Epilepsia; 2013 Jan; 54(1):126-34. PubMed ID: 22905878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topiramate in older patients with partial-onset seizures: a pilot double-blind, dose-comparison study.
    Ramsay RE; Uthman B; Pryor FM; Rowan AJ; Bainbridge J; Spitz M; Sirven JI; Frederick TE
    Epilepsia; 2008 Jul; 49(7):1180-5. PubMed ID: 18494791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs.
    Dodick DW; Freitag F; Banks J; Saper J; Xiang J; Rupnow M; Biondi D; Greenberg SJ; Hulihan J;
    Clin Ther; 2009 Mar; 31(3):542-59. PubMed ID: 19393844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topiramate in migraine prevention: results of a large controlled trial.
    Silberstein SD; Neto W; Schmitt J; Jacobs D;
    Arch Neurol; 2004 Apr; 61(4):490-5. PubMed ID: 15096395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term safety and efficacy in patients with uncontrolled partial-onset seizures treated with adjunctive lacosamide: results from a Phase III open-label extension trial.
    Husain A; Chung S; Faught E; Isojarvi J; McShea C; Doty P
    Epilepsia; 2012 Mar; 53(3):521-8. PubMed ID: 22372628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjunctive levetiracetam in infants and young children with refractory partial-onset seizures.
    Piña-Garza JE; Nordli DR; Rating D; Yang H; Schiemann-Delgado J; Duncan B;
    Epilepsia; 2009 May; 50(5):1141-9. PubMed ID: 19243423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of refractory neonatal seizures with topiramate.
    Riesgo R; Winckler MI; Ohlweiler L; Ranzan J; Becker M; Salvador S; Magalhaes L; Ribeiro R
    Neuropediatrics; 2012 Dec; 43(6):353-6. PubMed ID: 23007795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical experience with open-label topiramate use in infants younger than 2 years of age.
    Watemberg N; Goldberg-Stern H; Ben-Zeev B; Berger I; Straussberg R; Kivity S; Kramer U; Brand N; Lerman-Sagie T
    J Child Neurol; 2003 Apr; 18(4):258-62. PubMed ID: 12760428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjunctive lamotrigine for partial seizures in patients aged 1 to 24 months.
    Piña-Garza JE; Levisohn P; Gucuyener K; Mikati MA; Warnock CR; Conklin HS; Messenheimer J
    Neurology; 2008 May; 70(22 Pt 2):2099-108. PubMed ID: 18077797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
    Diener HC; Bussone G; Van Oene JC; Lahaye M; Schwalen S; Goadsby PJ;
    Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and effectiveness of topiramate for the management of painful diabetic peripheral neuropathy in an open-label extension study.
    Donofrio PD; Raskin P; Rosenthal NR; Hewitt DJ; Jordan DM; Xiang J; Vinik AI;
    Clin Ther; 2005 Sep; 27(9):1420-31. PubMed ID: 16291415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.